APA (7th ed.) Citation

NK, M., CL, A., E, S., KL, H., F, R., J, B., . . . DO, B. (2022). Serine-arginine-rich protein kinase-1 inhibition for the treatment of diabetic retinopathy. American journal of physiology. Heart and circulatory physiology, 322(6), H1014. https://doi.org/10.1152/ajpheart.00001.2022

Chicago Style (17th ed.) Citation

NK, Malhi, et al. "Serine-arginine-rich Protein Kinase-1 Inhibition for the Treatment of Diabetic Retinopathy." American Journal of Physiology. Heart and Circulatory Physiology 322, no. 6 (2022): H1014. https://doi.org/10.1152/ajpheart.00001.2022.

MLA (9th ed.) Citation

NK, Malhi, et al. "Serine-arginine-rich Protein Kinase-1 Inhibition for the Treatment of Diabetic Retinopathy." American Journal of Physiology. Heart and Circulatory Physiology, vol. 322, no. 6, 2022, p. H1014, https://doi.org/10.1152/ajpheart.00001.2022.